X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (187) 187
female (113) 113
middle aged (104) 104
male (95) 95
adult (91) 91
oncology (90) 90
aged (87) 87
antineoplastic combined chemotherapy protocols - therapeutic use (43) 43
index medicus (38) 38
cancer (33) 33
chemotherapy (28) 28
aged, 80 and over (25) 25
lung neoplasms - drug therapy (25) 25
breast neoplasms - drug therapy (22) 22
prognosis (18) 18
time factors (18) 18
adolescent (17) 17
antineoplastic agents - therapeutic use (17) 17
combined modality therapy (17) 17
neoplasm staging (17) 17
doxorubicin - administration & dosage (16) 16
drug evaluation (16) 16
treatment outcome (16) 16
antineoplastic combined chemotherapy protocols - adverse effects (15) 15
etoposide - administration & dosage (15) 15
lung neoplasms - therapy (15) 15
antineoplastic agents - administration & dosage (14) 14
antineoplastic agents - adverse effects (14) 14
carcinoma (14) 14
lung neoplasms - pathology (14) 14
neoplasms - drug therapy (14) 14
radiotherapy (14) 14
cisplatin (13) 13
cisplatin - administration & dosage (13) 13
cyclophosphamide - administration & dosage (13) 13
lung cancer (13) 13
neoplasm metastasis (13) 13
respiratory system (13) 13
carboplatin (12) 12
drug therapy, combination (12) 12
medicine, general & internal (12) 12
megestrol acetate (12) 12
tumors (12) 12
carcinoma, small cell - drug therapy (11) 11
combination chemotherapy (11) 11
dose-response relationship, drug (11) 11
megestrol - analogs & derivatives (11) 11
pathology (11) 11
pharmacology & pharmacy (11) 11
radiation-therapy (11) 11
retrospective studies (11) 11
survival analysis (11) 11
survival rate (11) 11
drug administration schedule (10) 10
etoposide (10) 10
kinetics (10) 10
lung neoplasms - mortality (10) 10
neoplasms - complications (10) 10
survival (10) 10
acute disease (9) 9
apoptosis (9) 9
article (9) 9
care and treatment (9) 9
evaluation (9) 9
lung cancer, non-small cell (9) 9
megestrol - therapeutic use (9) 9
patients (9) 9
radiology, nuclear medicine & medical imaging (9) 9
trial (9) 9
blood cell count (8) 8
blood transfusion (8) 8
carcinoma, non-small-cell lung - drug therapy (8) 8
carcinoma, non-small-cell lung - therapy (8) 8
expression (8) 8
follow-up studies (8) 8
hematology (8) 8
megestrol - administration & dosage (8) 8
paclitaxel (8) 8
randomized trial (8) 8
southwest-oncology-group (8) 8
therapy (8) 8
tomography, x-ray computed (8) 8
usage (8) 8
brain neoplasms - secondary (7) 7
carcinoma, non-small-cell lung - pathology (7) 7
carcinoma, small cell - therapy (7) 7
cell lung-cancer (7) 7
cyclophosphamide (7) 7
doxorubicin (7) 7
immunohistochemistry (7) 7
lung cancer, small cell (7) 7
phase-ii trial (7) 7
research (7) 7
risk (7) 7
adenocarcinoma - drug therapy (6) 6
analysis (6) 6
biopsy (6) 6
blood platelets (6) 6
breast cancer (6) 6
breast neoplasms - pathology (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1985, Contemporary issues in oncology, ISBN 9780443082511, Volume 3, xvi, 336
Book
1987, ISBN 0808918303, xx, 412
Book
Journal Article
1995, Seminars in oncology, Volume 22, no. 3, suppl. 6., 150
Book
1980, Developments in oncology, ISBN 9024723582, Volume 2, xvi, 271
Book
Clinical Cancer Research, ISSN 1078-0432, 08/2017, Volume 23, Issue 15, pp. 4163 - 4169
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 10/2019, Volume 84, Issue 4, pp. 899 - 907
Given the evidence that coordinate inhibition of AKT induces autophagy, we studied the combination of the AKT inhibitor, MK-2206 with hydroxychloroquine (HCQ)... 
Phase I | Hydroxychloroquine | Medicine & Public Health | Oncology | Cancer Research | MK-2206 | AKT | Pharmacology/Toxicology | Autophagy | Anorexia | Level (quantity) | Statistical analysis | Exanthema | Diarrhea | Fatigue | AKT protein | Nausea | Anticancer properties | Hyperglycemia | Antitumor activity | Plasma levels | Solid tumors | Phagocytosis | Tumors
Journal Article
by Lundqvist, Andreas and van Hoef, Vincent and Zhang, Xiaonan and Wennerberg, Erik and Lorent, Julie and Witt, Kristina and Sanz, Laia Masvidal and Liang, Shuo and Murray, Shannon and Larsson, Ola and Kiessling, Rolf and Mao, Yumeng and Sidhom, John-William and Bessell, Catherine A and Havel, Jonathan and Schneck, Jonathan and Chan, Timothy A and Sachsenmeier, Eliot and Woods, David and Berglund, Anders and Ramakrishnan, Rupal and Sodre, Andressa and Weber, Jeffrey and Zappasodi, Roberta and Li, Yanyun and Qi, Jingjing and Wong, Philip and Sirard, Cynthia and Postow, Michael and Newman, Walter and Koon, Henry and Velcheti, Vamsidhar and Callahan, Margaret K and Wolchok, Jedd D and Merghoub, Taha and Lum, Lawrence G and Choi, Minsig and Thakur, Archana and Deol, Abhinav and Dyson, Gregory and Shields, Anthony and Haymaker, Cara and Uemura, Marc and Murthy, Ravi and James, Marihella and Wang, Daqing and Brevard, Julie and Monaghan, Catherine and Swann, Suzanne and Geib, James and Cornfeld, Mark and Chunduru, Srinivas and Agrawal, Sudhir and Yee, Cassian and Wargo, Jennifer and Patel, Sapna P and Amaria, Rodabe and Tawbi, Hussein and Glitza, Isabella and Woodman, Scott and Hwu, Wen-Jen and Davies, Michael A and Hwu, Patrick and Overwijk, Willem W and Bernatchez, Chantale and Diab, Adi and Massarelli, Erminia and Segal, Neil H and Ribrag, Vincent and Melero, Ignacio and Gangadhar, Tara C and Urba, Walter and Schadendorf, Dirk and Ferris, Robert L and Houot, Roch and Morschhauser, Franck and Logan, Theodore and Luke, Jason J and Sharfman, William and Barlesi, Fabrice and Ott, Patrick A and Mansi, Laura and Kummar, Shivaani and Salles, Gilles and Carpio, Cecilia and Meier, Roland and Krishnan, Suba and McDonald, Dan and Maurer, Matthew and Gu, Xuemin and Neely, Jaclyn and Suryawanshi, Satyendra and Levy, Ronald and Khushalani, Nikhil and Wu, Jennifer and Zhang, Jinyu and Basher, Fahmin and Rubinstein, Mark and Bucsek, Mark and Qiao, Guanxi and ...
Journal for ImmunoTherapy of Cancer, ISSN 2051-1426, 11/2016, Volume 4, Issue S1
Journal Article
Translational Lung Cancer Research, ISSN 2218-6751, 04/2017, Volume 6, Issue 2, pp. 196 - 211
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 12/2012, Volume 7, Issue 12, pp. 1807 - 1814
Many patients with oncogene-driven non–small-cell lung cancer (NSCLC) treated with tyrosine kinase inhibitors experience limited sites of disease progression.... 
anaplastic lymphoma kinase gene arrangement non–small-cell lung cancer | EGFR-mutant non–small-cell lung cancer | Radiation therapy | Oligoprogressive disease | anaplastic lymphoma kinase gene arrangement non-small-cell lung cancer | EGFR-mutant non-small-cell lung cancer | PHASE-I/II TRIAL | ACQUIRED-RESISTANCE | BODY RADIATION-THERAPY | DOSE WEEKLY ERLOTINIB | BREAST-CANCER | LIVER METASTASES | SYNCHRONOUS BRAIN METASTASES | STEREOTACTIC RADIOSURGERY | ONCOLOGY | LEPTOMENINGEAL METASTASES | RESPIRATORY SYSTEM | RECURRENT MALIGNANT GLIOMAS | Erlotinib Hydrochloride | Receptor, Epidermal Growth Factor - genetics | Pyrazoles - therapeutic use | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Catheter Ablation | Lung Neoplasms - pathology | Male | Young Adult | Brain Neoplasms - secondary | Aged, 80 and over | Adult | Female | Retrospective Studies | Brain Neoplasms - mortality | Pyridines - therapeutic use | Carcinoma, Non-Small-Cell Lung - pathology | Survival Rate | Combined Modality Therapy | Lung Neoplasms - therapy | Mutation - genetics | Carcinoma, Non-Small-Cell Lung - mortality | Disease Progression | Carcinoma, Non-Small-Cell Lung - therapy | Receptor Protein-Tyrosine Kinases - genetics | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Gene Rearrangement | Brain Neoplasms - therapy | Aged | Neoplasm Staging
Journal Article
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 7/2014, Volume 74, Issue 1, pp. 177 - 183
Patients with recurrent small-cell lung cancer (SCLC) have dismal outcomes. The failure of salvage therapy is due to the possible development of resistance... 
Bcl-2 | Medicine & Public Health | Interferon alpha | Oncology | Cancer Research | 13- cis -retinoic acid | Pharmacology/Toxicology | Small-cell lung cancer | 13-cis-retinoic acid | APOPTOSIS | PROTEIN | PHASE-II | CHEMOTHERAPY | TRIAL | ETOPOSIDE | THERAPY | ONCOLOGY | PROSTATE-CANCER | RESISTANCE | PHARMACOLOGY & PHARMACY | CARCINOMA | Leukocytes, Mononuclear - metabolism | Lung Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Isotretinoin - therapeutic use | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Neoplasm Recurrence, Local - drug therapy | Isotretinoin - administration & dosage | Male | Proto-Oncogene Proteins c-bcl-2 - blood | Small Cell Lung Carcinoma - drug therapy | Small Cell Lung Carcinoma - blood | Chemotherapy-Induced Febrile Neutropenia - physiopathology | Early Termination of Clinical Trials | Leukopenia - chemically induced | Female | Paclitaxel - administration & dosage | Neoplasm Recurrence, Local - blood | Severity of Illness Index | Carcinoma, Small Cell - drug therapy | Interferon-alpha - therapeutic use | Leukopenia - physiopathology | Paclitaxel - adverse effects | Carcinoma, Small Cell - blood | Biomarkers - blood | Paclitaxel - therapeutic use | Interferon-alpha - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors | Interferon-alpha - adverse effects | Lung Neoplasms - blood | Isotretinoin - adverse effects | Cohort Studies | Relapse | Lung cancer | Analysis | Oncology, Experimental | Development and progression | Research | Biological response modifiers | Tretinoin | Cancer | Diseases | Index Medicus | small cell lung cancer | interferon alpha
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 94, Issue 1, pp. 147 - 154
Journal Article
Translational Lung Cancer Research, ISSN 2218-6751, 10/2017, Volume 6, Issue 5, p. 612
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.